Curcumin Extract

 

Garcea, G., et al., 2004. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer, 90(5), 1011-1015. PMID: 14997198

 

Iqbal, M., et al., 2003. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacology & Toxicology, 92(1), 33-38. PMID: 12710595

 

Shoba, G. et al., 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353-356. PMID: 9619120

 

Thapliyal, R. & Maru, G.B., 2001. Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food and Chemical Toxicology, 39(6), 541-547. PMID: 11346483

 

Zheng, S., Yumei, F. & Chen, A., 2007. De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radical Biology and Medicine, 43(3), 444-453. PMID: 17602960

 

Int J Biochem Cell Biol. 2009 Jan;41(1):40-59. doi: 10.1016/j.biocel.2008.06.010. Epub 2008 Jul 9.

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Aggarwal BB, Harikumar KB.

 

Trends Pharmacol Sci. 2009 Feb;30(2):85-94. doi: 10.1016/j.tips.2008.11.002. Epub 2008 Dec 26.

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.

Aggarwal BB, Sung B.

 

Curr Drug Targets. 2011 Mar 1;12(3):332-47.

The targets of curcumin.

Zhou H, Beevers CS, Huang S.

Joomla SEO powered by JoomSEF